托卡朋

托卡朋 基本信息
CAS号 134308-13-7 分子式 C14H11NO5
分子量 273.24100 精确质量 　273.06400
PSA 　103.35000 LogP 　3.06860
我要卖该产品 我要采购该产品
充值推广 查看更多供应商
目录
基本信息 物化性质 合成路线 毒性 上下游

基本信息 展开↓

CAS号：
134308-13-7
3D弹球模型：
立即前往扯扯看
分子式：
C14H11NO5
分子量：
273.24100
中文名称：
托卡朋
英文名称：
(3,4-dihydroxy-5-nitrophenyl)-(4-methylphenyl)methanone
中文别名：
托卡朋;
甲磺酸达氟沙星.甲达沙星.甲磺酸丹诺沙星;
(3,4-二羟基-5-硝基苯基)-(4-甲基苯基)甲酮
英文别名：
(3,4-dihydroxy-5-nitrophenyl)-(4-methylphenyl)methanone;
(3,4-Dihydroxy-5-nitrophenyl)(4-methylphenyl)methanone;
Tasmar;
Tolcapone;
3,4-Dihydroxy-4'-methyl-5-nitrobenzophenone;
1-(3,4-dihydroxy-5-nitrophenyl)-1-(4-methylphenyl)methanone;
UNII-CIF6334OLY;
Tasmar (TN);
Methanone,(3,4-dihydroxy-5-nitrophenyl)(4-methylphenyl);
4'-methyl-3,4-dihydroxy-5-nitro-benzophenone;
[14C]-Tolcapone;
Ro 40-7592
精确分子量/精确质量：
273.06400
极性分子表面积/PSA：
103.35000
油水分配系数/LogP：

LogP值指的是某物质在正辛醇/水两相体系中的分配系数的对数值，反映了物质在油水两相中的分配情况。其中、LogP值越大，说明该物质越亲油；反之，LogP值越小，则说明该物质越亲水。
InChI：
InChI=1/C14H11NO5/c1-8-2-4-9(5-3-8)13(17)10-6-11(15(19)20)14(18)12(16)7-10/h2-7,16,18H,1H3

物化性质展开↓

密度：
1.419g/cm3
熔点：
126-128ºC
沸点：
485.6ºC at 760mmHg
闪点：
205.8°C
折射率：
1.661
蒸汽压：
4.72E-10mmHg at 25°C

合成路线查看所有的合成路线

  • 134612-80-9

    1-(4-羟基-3-甲氧基-5-硝基苯基)-3-(4-甲基苯基)丙-2-酮

  • →

    ~92%

  • 134308-13-7

    托卡朋

毒理性展开↓

CHEMICAL IDENTIFICATION

RTECS NUMBER :
PC4952500
CHEMICAL NAME :
Methanone, (3,4-dihydroxy-5-nitrophenyl)(4-methylphenyl)-
CAS REGISTRY NUMBER :
134308-13-7
LAST UPDATED :
199709
DATA ITEMS CITED :
8
MOLECULAR FORMULA :
C14-H11-N-O5
MOLECULAR WEIGHT :
273.26

HEALTH HAZARD DATA

ACUTE TOXICITY DATA

TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
>2 gm/kg
TOXIC EFFECTS :
Behavioral - somnolence (general depressed activity) Behavioral - ataxia Lungs, Thorax, or Respiration - respiratory depression
REFERENCE :
YACHDS Yakuri to Chiryo. Pharmacology and Therapeutics. (Raifu Saiensu Shuppan K.K., 2-5-13, Yaesu, Chuo-ku, Tokyo 104, Japan) V.1- 1972- Volume(issue)/page/year: 24(Suppl 10),S1513,199
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
1600 mg/kg
TOXIC EFFECTS :
Behavioral - somnolence (general depressed activity) Behavioral - ataxia Lungs, Thorax, or Respiration - respiratory depression
REFERENCE :
YACHDS Yakuri to Chiryo. Pharmacology and Therapeutics. (Raifu Saiensu Shuppan K.K., 2-5-13, Yaesu, Chuo-ku, Tokyo 104, Japan) V.1- 1972- Volume(issue)/page/year: 24(Suppl 10),S1513,199 ** OTHER MULTIPLE DOSE TOXICITY DATA **
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
9300 mg/kg/4W-I
TOXIC EFFECTS :
Liver - changes in liver weight Related to Chronic Data - death
REFERENCE :
YACHDS Yakuri to Chiryo. Pharmacology and Therapeutics. (Raifu Saiensu Shuppan K.K., 2-5-13, Yaesu, Chuo-ku, Tokyo 104, Japan) V.1- 1972- Volume(issue)/page/year: 24(Suppl 10),S1521,199
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
91 gm/kg/26W-C
TOXIC EFFECTS :
Nutritional and Gross Metabolic - weight loss or decreased weight gain
REFERENCE :
YACHDS Yakuri to Chiryo. Pharmacology and Therapeutics. (Raifu Saiensu Shuppan K.K., 2-5-13, Yaesu, Chuo-ku, Tokyo 104, Japan) V.1- 1972- Volume(issue)/page/year: 24(Suppl 10),S1557,199
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Mammal - dog
DOSE/DURATION :
1120 mg/kg/4W-I
TOXIC EFFECTS :
Gastrointestinal - alteration in gastric secretion Kidney, Ureter, Bladder - other changes
REFERENCE :
YACHDS Yakuri to Chiryo. Pharmacology and Therapeutics. (Raifu Saiensu Shuppan K.K., 2-5-13, Yaesu, Chuo-ku, Tokyo 104, Japan) V.1- 1972- Volume(issue)/page/year: 24(Suppl 10),S1537,199
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Mammal - dog
DOSE/DURATION :
25830 mg/kg/26W-I
TOXIC EFFECTS :
Gastrointestinal - hypermotility, diarrhea Gastrointestinal - nausea or vomiting
REFERENCE :
YACHDS Yakuri to Chiryo. Pharmacology and Therapeutics. (Raifu Saiensu Shuppan K.K., 2-5-13, Yaesu, Chuo-ku, Tokyo 104, Japan) V.1- 1972- Volume(issue)/page/year: 24(Suppl 10),S1585,199
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Mammal - dog
DOSE/DURATION :
1760 mg/kg/15D-I
TOXIC EFFECTS :
Gastrointestinal - hypermotility, diarrhea Gastrointestinal - nausea or vomiting
REFERENCE :
YACHDS Yakuri to Chiryo. Pharmacology and Therapeutics. (Raifu Saiensu Shuppan K.K., 2-5-13, Yaesu, Chuo-ku, Tokyo 104, Japan) V.1- 1972- Volume(issue)/page/year: 24(Suppl 10),S1513,199 ** REPRODUCTIVE DATA **
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Oral
DOSE :
3 gm/kg
SEX/DURATION :
female 6-15 day(s) after conception
TOXIC EFFECTS :
Reproductive - Maternal Effects - other effects
REFERENCE :
YACHDS Yakuri to Chiryo. Pharmacology and Therapeutics. (Raifu Saiensu Shuppan K.K., 2-5-13, Yaesu, Chuo-ku, Tokyo 104, Japan) V.1- 1972- Volume(issue)/page/year: 24(Suppl 10),S1631,199

上下游相关产品

上游产品

更多

  • 134612-80-9

    1-(4-羟基-3-甲氧基-5-硝基苯基)-3-(4-甲基苯基)丙-2-酮

立即下载安装“化学加”APP
专业、功能强大，随时调用更加方便
下载APP